<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Natural Science Foundation 10.13039/501100003995 1708085QH207 National Natural Science Foundation of" exact="China" post="10.13039/501100001809 8180360281970584 fig-count: table-count: page-count: word-count: ZhouH, FangY, XuT,"/>
 <result pre="the ability to infect humans. Subsequently, it spread rapidly throughout" exact="China" post="and caused outbreaks in many other countries, including Japan,"/>
 <result pre="China and caused outbreaks in many other countries, including Japan," exact="South Korea," post="Italy, and the United States (Zhu et al., 2020)."/>
 <result pre="in many other countries, including Japan, South Korea, Italy, and" exact="the United States" post="(Zhu et al., 2020). On January 31, 2020, the"/>
 <result pre="many other countries, including Japan, South Korea, Italy, and the" exact="United States" post="(Zhu et al., 2020). On January 31, 2020, the"/>
 <result pre="causing outbreaks of SARSâ€�like clinical symptoms in Wuhan city of" exact="China" post="and was officially designated SARSâ€�CoVâ€�2 by the WHO. SARSâ€�CoVâ€�2"/>
 <result pre="(Inoue, 2020). As these two drugs have been prescribed in" exact="Japan" post="for many years and have adequate clinical data with"/>
 <result pre="expected treatment effect in a patient infected with SARSâ€�CoVâ€�2 in" exact="the United States" post="attracted much attention (Holshue et al., 2020). Currently, remdesivir"/>
 <result pre="treatment effect in a patient infected with SARSâ€�CoVâ€�2 in the" exact="United States" post="attracted much attention (Holshue et al., 2020). Currently, remdesivir"/>
 <result pre="(such as ChiCTR2000029539, ChiCTR2000029603, and ChiCTR2000029759) have been approved in" exact="China" post="to test the effectiveness of HIV protease inhibitors such"/>
 <result pre="by experts of the Academy of Military Medical Sciences of" exact="China" post="and was approved for clinical trials (Zhang, 2020b). The"/>
 <result pre="statistics, a total of 60,107 patients infected with SARSâ€�CoVâ€�2 in" exact="China" post="were treated with TCM by February 17, 2020. A"/>
 <result pre="SARSâ€�CoVâ€�2. 4 CONCLUDING REMARKS Although the outbreak of SARSâ€�CoVâ€�2 in" exact="China" post="was contained by the joint efforts of the government,"/>
 <result pre="medical staff, outbreaks in other countries and regions outside of" exact="China" post="have become increasingly severe and uncontrollable. By April 9,"/>
 <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(No. 81803602 and 81970584), the Anhui Provincial Natural Science"/>
 <result pre="camelid nanobodies. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 110(15), E1371â€&quot;E1379. 10.1073/pnas.130133611023530214 Dong, L., Hu, S.,"/>
 <result pre="nanobodies. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="110(15), E1371â€&quot;E1379. 10.1073/pnas.130133611023530214 Dong, L., Hu, S., &amp;amp; Gao,"/>
 <result pre="broad spectrum inhibitor of viral RNA polymerase. Proceedings of the" exact="Japan" post="Academy. Series B, Physical and Biological Sciences, 93(7), 449â€&quot;463."/>
 <result pre="S. K. (2020). First case of 2019 novel coronavirus in" exact="the United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
 <result pre="K. (2020). First case of 2019 novel coronavirus in the" exact="United States." post="The New England Journal of Medicine, 382(10), 929â€&quot;936. 10.1056/NEJMoa200119132004427"/>
 <result pre="convalescent plasma in 2 patients with Ebola virus disease in" exact="the United States." post="Clinical Infectious Diseases, 61(4), 496â€&quot;502. 10.1093/cid/civ33425904375 Kruse, R. L."/>
 <result pre="plasma in 2 patients with Ebola virus disease in the" exact="United States." post="Clinical Infectious Diseases, 61(4), 496â€&quot;502. 10.1093/cid/civ33425904375 Kruse, R. L."/>
 <result pre="ligase RCHY1. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 113(35), E5192â€&quot;E5201. 10.1073/pnas.160343511327519799 Masters, P. S. (2006)."/>
 <result pre="RCHY1. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="113(35), E5192â€&quot;E5201. 10.1073/pnas.160343511327519799 Masters, P. S. (2006). The molecular"/>
 <result pre="human coronavirus. Proceedings of the National Academy of Sciences of" exact="the United States" post="of America, 101(27), 10012â€&quot;10017. 10.1073/pnas.040359610115226499 Xia, S., Liu, M.,"/>
 <result pre="coronavirus. Proceedings of the National Academy of Sciences of the" exact="United States of America," post="101(27), 10012â€&quot;10017. 10.1073/pnas.040359610115226499 Xia, S., Liu, M., Wang, C.,"/>
 <result pre="Molecular Immunology, 11, 1â€&quot;3. 10.1038/s41423-020-0374-2 collab: Xinhua Daily . (2020)." exact="China" post="optimizes treatment for COVIDâ€�19. Retrieved from http://english.www.gov.cn/news/topnews/202003/07/content_WS5e62fff1c6d0c201c2cbdb82.html Xu, X.,"/>
</results>
